Record Financial Performance
2025 consolidated net sales up ~55% to $1.90B; adjusted EBITDA up ~59% to $349M; adjusted EPS $0.72, up 20% year-over-year — achieved despite a weak industry backdrop.
Successful Mattress Firm Combination and Upsized Synergy Targets
Combination executed and integrated under a holding structure; total EBITDA synergies increased to $225M (cost synergies $125M; sales synergies $100M). Cost synergies: $20M realized in 2025, $55M expected in 2026, $50M in 2027. Sales synergies: $60M realized in 2025 with an incremental $40M expected in 2026 toward a $100M run-rate target. Company is now ~65% direct-to-consumer.
International Growth Momentum
International net sales grew ~13% reported and ~9% on a constant currency basis; international gross margin expanded ~40 bps to 51.1% and operating margin improved ~110 bps to 22.4%, driven by product lineup, distribution expansion and marketing.
North America Tempur‑Sealy Outperformance and Margin Expansion
Like-for-like Tempur‑Sealy wholesale net sales rose ~6% in Q4; North American like-for-like gross margin improved ~250 bps and adjusted operating margin expanded ~450 bps year-over-year (reported NA adjusted gross margin benefited from intercompany elimination and was reported at ~59.5%).
Mattress Firm Operational & Marketing Wins
Mattress Firm delivered stronger-than-market results with adjusted gross margin of 32.4% and adjusted operating margin of 5.4%; launched Sealy Posturepedic (largest launch in company history) with >65,000 additional samples shipped; new 'Sleep Easy' campaign achieved all-time high market research scores and attracted incremental advertising commitments from third-party vendors. Company plans $150M of Mattress Firm store refresh investments (2025–2027) and expanded Tempur brand wall rollout to drive higher retail ASP.
Capital Allocation Discipline and Shareholder Returns
Leverage improved to 3.2x (down nearly one-third of a turn vs acquisition date) with consolidated net debt (debt less cash) of $4.6B; target leverage of 2–3x expected within six months. Board increased quarterly dividend 13% to $0.17 (sixth consecutive year of increases).
2026 Guidance and Upgraded Long‑Term Targets
2026 adjusted EPS guidance of $3.00–$3.40 with a sales midpoint of ~$7.9B (after intercompany eliminations); adjusted EBITDA implied around $1.45B at midpoint. Raised 2028 EPS target to $5.15 (24% CAGR from 2025) with targets of mid-single digit annual sales growth and double-digit annual adjusted EBITDA growth.
Significant Marketing Investment to Drive Demand
Company plans substantial advertising support (~$720M referenced) to support launches, brand awareness and retail traffic as part of a demand-driving strategy tied to expected share gains.